New Mechanism Behind Melanoma Drug Resistance Uncovered
Scientists have identified a novel resistance mechanism in melanoma where a long non-coding RNA activates the Hippo pathway to promote drug resistance. This discovery could lead to new combination therapies for treatment-resistant melanoma patients.
